Because according to Bulios' fair price, it's now 33% undervalued! What more do you need to know?! :-D
No seriously, it seems like a healthy company with tradition that has invested nicely now and is at a fine price for me.

:DD this is just another reason to buy!

I already have it! And I will definitely increase the position :)

I really like their acquisitions, fundamentals and they provide a lot of services and it's one of the best companies in this sector. Otherwise there is a lot of room for growth in the stock and the dividend is nice too :)

I couldn't have said it better.

:D

In addition to what is already here, I personally see a lot of room for upside in terms of the chart. 🙂 Plus, now that we're looking at the chart, there's a great buying opportunity... We're at a multi-tested and strong trendline from 2003.. 🙂 We're at a multi-tested and strong trendline from 2003.

You're also buying pumped-up shares of this company?

No longer am I just going purely stock to hold long term no leverage.

And do you have this technical analysis available anywhere? I'd like to see it. :)

It's a pity that you can't post some previews here, for example just from TW, to limit that someone won't put a bad picture here. But I can put a link to such a brief TA https://www.tradingview.com/x/efAftEY7/

For me, it's mainly decent management and fairly aggressive acquisitions that will lead to expansion. It's also a nice FCF yield. The business vertical that Philip mentions creates a strong moat.

Last but not least, it's the trust in some who are also invested.

I agree. :)

That made me laugh😅 $CVS+2.0% is awesome and I have it in my portfolio. I don't think there's anything quite like it.

:D don't you have any more stocks in the healthcare sector?

I don't. I don't know much about this sector.

It is one of the largest companies in the sector in my opinion that has a network of pharmacies, drug delivery and also the healthcare segment is good. There are a lot of companies that are developing things etc, but that's where I think it's tricky, it depends on them developing something and possibly getting it approved. Whereas with these companies like $CVS+2.0%, then it's "just" selling it. Admittedly, an insurance company recently stopped working with them, but that supposedly didn't even account for about 10% of their revenue. That may have been responsible for the decline. I took advantage of that and kept buying.

Thanks for your perspective, I agree with you. :)

👍😊